X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
SUN PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 265.5%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Markets will remain closed on 19th April, 2019 on account of Good Friday.

SUN PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 265.5%
Wed, 13 Feb

SUN PHARMA has announced its results for the quarter ended December 2018. Here is a detailed performance review of the same:

SUN PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-17*
3
Sep-18*
3
Dec-18*
QoQ ChangeYoY Change
Net SalesRs m66,53269,37677,40211.6%16.3%
Other incomeRs m1,2923,5121,931-45.0%49.4%
TurnoverRs m67,82472,88879,3338.8%17.0%
ExpensesRs m51,99954,06455,8733.3%7.5%
Gross profitRs m14,5343,16821,529579.5%48.1%
DepreciationRs m3,3934,2654,71110.4%38.8%
InterestRs m9531,2951,44811.8%51.9%
Profit before taxRs m11,4791,11917,3011445.6%50.7%
TaxRs m7,4872,1892,70923.8%-63.8%
Profit after taxRs m3,992-1,07014,592265.5%
Gross profit margin%21.84.627.8
Effective tax rate%65.2195.615.7
Net profit margin%5.9-1.518.4
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 16.3% on a year-on-year (YoY) basis. The expenses were up by 7.5% YoY during the same period.
  • The company's operating profit increased by 48.1% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 27.8% in 3QFY19 as against 21.8% in 3QFY18.
  • Depreciation charges increased by 38.8% and finance costs increased by 51.9% YoY, respectively.
  • Other income increased by 49.4% YoY during the quarter.
  • Net profit for the quarter increased by 265.5% YoY. Net profit margins during the quarter increased from 5.9% in 3QFY18 to 18.4% in 3QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 11.6% on a quarter-on-quarter (QoQ) basis. The expenses were up by 3.3% QoQ during the same period.
  • The company's operating profit increased by 579.5% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 27.8% in 3QFY19 as against 4.6% in 2QFY18.
  • Net profit for the quarter increased by 1464.1% QoQ, while net profit margins increased from -1.5% in 2QFY18 to 18.4% in 3QFY19.

To see how SUN PHARMA has performed over the last eight quarters, please visit here.

SUN PHARMA Share Price Performance

Over the last one year, SUN PHARMA share price has moved up from Rs 589.4 to Rs 453.0, registering a Loss of Rs 136.4 or around 23.1%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,859.9 (up 0.7%). Over the last one year it has moved down from 14,517.2 to 13,859.9, a gain of 657 points (down 4.5%).

Overall, the S&P BSE SENSEX is up 5.8% over the year.

Current Valuations

At the current price of Rs 453.0, the price to earnings (P/E) ratio of SUN PHARMA stands at 27.2 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 2.9 times.

Equitymaster requests your view! Post a comment on "SUN PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 265.5%". Click here!

  

Related Views on News

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 110.7% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, SUN PHARMA has posted a net profit of Rs 1 bn (down 110.7% YoY). Sales on the other hand came in at Rs 69 bn (up 4.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 446.1% (Quarterly Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

For the quarter ended June 2018, SUN PHARMA has posted a net profit of Rs 11 bn (up 446.1% YoY). Sales on the other hand came in at Rs 72 bn (up 16.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Apr 18, 2019 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUN PHARMA WITH

MARKET STATS